Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Kiadis Pharma Netherlands BV

www.kiadis.com

Latest From Kiadis Pharma Netherlands BV

Finance Watch: Big Money For Big Goals Met By Reata, CRISPR, Karuna

Public Company Edition: Also, Teva sells $2.1bn in notes to pay prior debts. In restructurings, Baudax splits off from Recro, while three firms shift their focus to specific cell therapy programs.

Financing Business Strategies

Roche’s Polivy Among Seven New Drugs On Track For EU-Wide Approval

Seven drugs, including two orphans and two generics, are on track to receive pan-EU approval.

Europe Approvals

Jumping Before They Were Pushed – Kiadis And Aradigm Withdraw EU Filings

Notice of the withdrawal of pan-EU marketing authorizations applications by Kiadis Pharma and Aradigm are noted in the agenda of the latest meeting of the European Medicines Agency's key scientific committee, the CHMP. 

Drug Review Europe

First Ebola Vaccine Among Seven Products To Get EMA Nod

Seven new products, including the world’s first ever Ebola vaccine, are on track to receive EU-wide approval. Meanwhile, two drugs have failed to make the grade.

Approvals Europe
See All

Company Information

  • Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
  • Pharmaceuticals
    • Vaccines
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Kiadis BV
  • Screentec BV
  • Kiadis Pharma BV
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Benelux
          • Netherlands
  • Parent & Subsidiaries
  • Kiadis Pharma Netherlands BV
  • Senior Management
  • Arthur Lahr, PhD, CEO
    Scott A Holmes, CFO
    Dirk de Naeyer, COO
    Andrew Sandler, MD, CMO
    Robert Friesen, PhD, CSO
  • Contact Info
  • Kiadis Pharma Netherlands BV
    Phone: (31) 20 314 02 50
    Paasheuvelweg 25A
    Amsterdam-Zuidoost, 1105 BP
    Netherlands
UsernamePublicRestriction

Register